Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 v2.3.0.11
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 9 Months Ended
Jun. 30, 2011
Jun. 30, 2010
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (6,170,400) $ (4,753,200)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 8,700 7,200
Amortization of discount on bridge notes issued 2,897,700 37,500
Stock-based compensation 1,225,400 859,900
Issuance of warrants for financing services 183,500 0
Gain on derivative liability valuation (4,753,100) 0
Non-cash interest expense 3,171,800 0
Doubtful debt write-off 0 13,400
Changes in operating assets and liabilities:    
Accounts receivable (1,100) (8,000)
Prepaids and other current assets 17,800 (16,100)
Accounts payable 75,400 (169,300)
Accrued liabilities 83,400 69,000
Deferred compensation 24,100 17,500
Accrued patient costs 0 (161,500)
Security deposits on leases 100 (14,600)
Net cash used in operating activities (3,236,700) (4,118,200)
CASH FLOWS FROM INVESTING ACTIVITIES    
Acquisition of office furniture and equipment (19,700) (8,900)
Net cash used in investing activities (19,700) (8,900)
CASH FLOWS FROM FINANCING ACTIVITIES    
Repayment of note (24,700) (69,800)
Repayment of lease (3,800) (1,500)
New equipment lease 15,900 0
Proceeds from bridge notes - secured 1,900,000 250,000
Proceeds from bridge notes - unsecured 2,500,000 0
Prepaid offering costs (282,300) 0
Proceeds from sale of common stock, net of offering costs 0 2,995,400
Net cash provided by financing activities 4,105,100 3,174,100
Net increase (decrease) in cash 848,700 (953,000)
Cash, beginning of period 62,000 988,100
Cash, end of period 910,700 35,100
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest 1,800 8,200
Income taxes 1,300 2,400
Non-cash financing activities:    
Shares issued for accounts payable $ 44,000 $ 0